In the animal model of MS, experimental autoimmune encephalomyelitis (EAE), neutralization of HMGB1 ameliorated clinical severity, reduced central nervous system pathology, and blocked pro-inflammatory cytokine production [9,10]. Here, HMGB1 is linked to myeloid sarcoma.